Garlic, Vitamin, and Antibiotic Treatment for Helicobacter pylori: A Randomized Factorial Controlled Trial
NCI-Frederick, Фредерик, Maryland, United States Helicobacter
(Impact Factor: 4.11).
11/2007; 12(5):575-8. DOI: 10.1111/j.1523-5378.2007.00528.x
Available from: Hyeyoung Kim
- "However, dietary intervention studies have been relatively less successful than in vivo and in vitro experimental studies. The effects of curcumin, vitamin C, vitamin E, selenium, and garlic have been investigated in individuals infected with H. pylori [57–60]. However, they showed limited or no effects on bacterial load or the inflammatory response induced by H. pylori. "
[Show abstract] [Hide abstract]
ABSTRACT: Helicobacter pylori is an important risk factor for gastric inflammation, which is mediated by multiple signaling pathways. The aim of this study was to investigate the effects of polyunsaturated fatty acids (PUFAs), such as linoleic acid (LA), alpha-linolenic acid (ALA), and docosahexaenoic acid (DHA), on the expression of the proinflammatory chemokine interleukin-8 (IL-8) in H. pylori-infected gastric epithelial AGS cells. To investigate whether PUFAs modulate H. pylori-induced inflammatory signaling, we determined the activation of epidermal growth factor receptor (EGFR), protein kinase C- δ (PKC δ ), mitogen-activated protein kinases (MAPKs), nuclear factor-kappa B (NF- κ B), and activator protein-1 (AP-1) as well as IL-8 expression in H. pylori-infected gastric epithelial cells that had been treated with or without PUFAs. We found that PUFAs inhibited IL-8 mRNA and protein expression in H. pylori-infected cells. ω -3 fatty acids (ALA, and DHA) suppressed the activation of EGFR, PKC δ , MAPK, NF- κ B, and AP-1 in these infected cells. LA did not prevent EGFR transactivation and exhibited a less potent inhibitory effect on IL-8 expression than did ALA and DHA. In conclusion, PUFAs may be beneficial for prevention of H. pylori-associated gastric inflammation by inhibiting proinflammatory IL-8 expression.
Mediators of Inflammation 06/2014; 2014(196):128919. DOI:10.1155/2014/128919 · 3.24 Impact Factor
Available from: Jeremy J. Gilbreath
- "Similarly, turmeric/curcumin (Koosirirat et al., 2010), chili (Lee et al., 2007b), and oregano (Lin et al., 2005) have been shown to have varying levels of bacteriocidal effects against H. pylori. Furthermore, garlic extracts and its active ingredient , allicin, have been shown to contain H. pylori growth inhibitory properties when tested in vitro (Canizares et al., 2002, 2004), in vivo in animal models (Iimuro et al., 2002), as well as in clinical trials (Martin and Ernst, 2003; Gail et al., 2007). Moreover, several studies have shown a reduced risk of gastric cancer with increased consumption of allium containing vegetables such as onions and garlic (Jonkers et al., 1999); this effect may possibly be due to an effect on H. pylori. "
[Show abstract] [Hide abstract]
ABSTRACT: The Gram-negative pathogen Helicobacter pylori is increasingly more resistant to the three major antibiotics (metronidazole, clarithromycin and amoxicillin) that are most commonly used to treat infection. As a result, there is an increased rate of treatment failure; this translates into an overall higher cost of treatment due to the need for increased length of treatment and/or the requirement for combination or sequential therapy. Given the rise in antibiotic resistance, the complicated treatment regime, and issues related to patient compliance that stem from the duration and complexity of treatment, there is clearly a pressing need for the development of novel therapeutic strategies to combat H. pylori infection. As such, researchers are actively investigating the utility of antimicrobial peptides, small molecule inhibitors and naturopathic therapies. Herein we review and discuss each of these novel approaches as a means to target this important gastric pathogen.
The Journal of Microbiology 04/2014; 52(4):259-72. DOI:10.1007/s12275-014-3603-5 · 1.44 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Objective|In cancer prevention, the targeting of precancerous lesions has been recognized as the most promising method. However, little
attention has been paid to the risk factors of precancerous gastric lesions, especially in rural China where there is high
prevalence of precancerous gastric lesions. We therefore conducted a cross-sectional study in Liaoning province, China, to
investigate the potential risk and protective factors of these precancerous gastric lesions.
MethodsA total of 1,179 subjects with high risk of gastric cancer from Zhuanghe County were included in this study. Standard questionnaires
were used in collecting epidemiological factors and the data were then analyzed by the unconditional logistic regression model.
ResultsSmoking and drinking were the risk factors for the precancerous gastric lesions among rural subjects, and the association
of smoking or drinking and the precancerous gastric lesions increased in strength with the daily consumption and duration.
As the factors such as age, gender, smoking, alcohol were controlled, a multivariable analysis revealed that there was a significant
correlation between the deep-fry food intake and the gastric epithelial dysplasia with the odds ratio (OR) of 1.78 [95% confidence
interval (CI): 1.01–3.12]. Garlic eating was shown to confer protection against the development of gastric ulcer (OR=0.55, 95% CI: 0.33–0.92).
ConclusionSmoking and drinking were the risk factors for the precancerous gastric lesions among rural subjects. Deep-fry food intake
might be one of the risk factors for the precancerous gastric lesions and garlic eating was shown to confer protection against
the development of gastric ulcer among rural Chinese population.
Key wordsRisk factors-Precancerous gastric lesions-High risk of gastric cancer
Chinese Journal of Cancer Research 12/2010; 22(4):267-273. DOI:10.1007/s11670-010-0267-5 · 1.94 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.